Novartis announced Monday morning that it has acquired DtX Pharma, a San Diego-based biopharma, in an effort to bolster its neuroscience capabilities. As part of the deal, Novartis is providing DtX ...
A portfolio company of Irvine-based Tech Coast Angels (TCA), an angel investment network for early-stage companies, was acquired last month for $500 million by Swiss drug giant Novartis AG (NYSE: NVS) ...
Gemini has recently been employed by analysts to forecast the future of DTX Exchange. According to its analysis, DTX Exchange (DTX) is expected to experience significant growth by 2025, potentially ...
Compared to the global market’s growth from $2.33 trillion to $2.52 trillion within a week, Avalanche (AVAX) has seen only modest gains. As a result, investors are increasingly turning to contenders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback